Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Xitao Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1138-3372; OpenAlex author ID A5024424422. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fgene.2021.763636↗
  2. CXCR4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic Cancer Cells Through Targeting HMGA2. First author DOI 10.1159/000481610↗
  3. MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironments. Last author DOI 10.1242/bio.021774↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhi Li · 1 shared paper, 2021 · strength 0.14
  2. Guangfa Xiao · 1 shared paper, 2017 · strength 0.12
  3. Yaqun Yu · 1 shared paper, 2017 · strength 0.12
  4. Yebin Lu · 1 shared paper, 2017 · strength 0.08
  5. Xuejun Gong · 1 shared paper, 2017 · strength 0.08
  6. Weijia Sun · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.